Boceprevir Versus Placebo with Pegylated Interferon Alfa-2b and Ribavirin for Treatment of Hepatitis C Virus Genotype 1 in Patients with HIV: A Randomised, Double-blind, Controlled Phase 2 Trial
Sulkowski M, Pol S, Mallolas J, Fainboim H, Cooper C, Slim J, Rivero A, Mak C, Thompson S, Howe AY, Wenning L, Sklar P, Wahl J, Greaves W
Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
Anette G. Ziegler, MD; Marian Rewers, MD, PhD; Olli Simell, MD, PhD; Tuula Simell, MPH, PhD; Johanna Lempainen, MD, PhD; Andrea Steck, MD; Christiane Winkler, PhD; Jorma Ilonen, MD, PhD; Riitta Veijola, MD, PhD; Mikael Knip, MD, PhD; Ezio Bonifacio, PhD; George S. Eisenbarth, MD, PhD
Effectiveness of Monovalent Rotavirus Vaccine in Bolivia: Case-control Study
Manish M Patel, epidemiologist, Maritza Patzi, epidemiologist, Desiree Pastor, epidemiologist, Aleida Nina, microbiologist, Yelin Roca, microbiologist, Leovigildo Alvarez, microbiologist, Volga Iniguez, research microbiologist, Rosario Rivera, microbiologist, Ka Ian Tam, microbiologist, Osbourne Quaye, microbiologist, Michael Bowen, research microbiologist, Umesh Parashar, epidemiologist, Lucia Helena De Oliveira, epidemiologist
Metformin vs. Glipizide for Patients with Diabetes and Coronary Disease
Metformin was associated with better cardiovascular outcomes.
Intake of Whole Grains from Different Cereal and Food Sources and Incidence of Colorectal Cancer in the Scandinavian HELGA Cohort
Kyrø C, Skeie G, Loft S, Landberg R, Christensen J, Lund E, Nilsson LM, Palmqvist R, Tjønneland A, Olsen A
Endosonography vs Conventional Bronchoscopy for the Diagnosis of Sarcoidosis
The GRANULOMA Randomized Clinical Trial
Martin B. von Bartheld, MD; Olaf M. Dekkers, MD, PhD; Artur Szlubowski, MD, PhD; Ralf Eberhardt, MD, PhD; Felix J. Herth, MD, PhD; Johannes C. C. M. in ‘t Veen, MD, PhD; Ynze P. de Jong, MD; Erik H. F. M. van der Heijden, MD, PhD; Kurt G. Tournoy, MD, PhD; Martin Claussen, MD, PhD; Bernt van den Blink, MD, PhD; Pallav L. Shah, MD, MBBS, FRCP; Zaid Zoumot, MBBS, MRCP; Paul Clementsen, MD, PhD; Celeste Porsbjerg, MD, PhD; Thais Mauad, MD, PhD; Fabiola D. Bernardi, MD, PhD; Erik W. van Zwet, PhD; Klaus F. Rabe, MD, PhD; Jouke T. Annema, MD, PhD
Use of 5α-reductase Inhibitors for Lower Urinary Tract Symptoms and Risk of Prostate Cancer in Swedish Men: Nationwide, Population Based Case-control Study
David Robinson, researcher, Hans Garmo, senior medical statistician, Anna Bill-Axelson, associate professor, Lorelei Mucci, associate professor, Lars Holmberg, professor, Pär Stattin, professor
In a large population-based screening study, the OC Sensor (Polymedco) test was superior to the Magstream test.
Experts widely agree that a fecal immunochemical test (FIT) should replace a guaiac-based fecal occult blood test for colorectal cancer (CRC) screening because of its higher adherence rates and superior performance characteristics. However, the performance characteristics of different FITs have been shown to vary dramatically (Ann Intern Med 2009; 150:162). Therefore, the clinical issue has not been whether to use a FIT, but which FIT to use. In the current study, investigators compared the OC Sensor FIT (Eiken Chemical Co., Tokyo, Japan), commonly studied in clinical trials, to the Magstream FIT (Fujirebio, Inc., Tokyo, Japan), and the Hemoccult II guaiac test (SKD, Villepinte, France).
Elective Caesarean Section at 38 Weeks Versus 39 Weeks: Neonatal and Maternal Outcomes in a Randomised Controlled Trial
Glavind J, Kindberg S, Uldbjerg N, Khalil M, Møller A, Mortensen B, Rasmussen O, Christensen J, Jørgensen J, Henriksen T
The Relationship Between Cytokine Gene Polymorphism and Unexplained Recurrent Spontaneous Abortion in Saudi Females
Afrah F. Alkhuriji, Ahmad R. Alhimaidi, Zeneb A. Babay, Arjumand S. Wary
